ES8203088A1 - Un metodo para la preparacion de 3,8-dialcohilxantinas - Google Patents
Un metodo para la preparacion de 3,8-dialcohilxantinasInfo
- Publication number
- ES8203088A1 ES8203088A1 ES501400A ES501400A ES8203088A1 ES 8203088 A1 ES8203088 A1 ES 8203088A1 ES 501400 A ES501400 A ES 501400A ES 501400 A ES501400 A ES 501400A ES 8203088 A1 ES8203088 A1 ES 8203088A1
- Authority
- ES
- Spain
- Prior art keywords
- processes
- butyl
- ethyl
- compounds
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE 3,8-DIALCOHILXANTINAS O SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R1 Y R2 PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA R2X, EN LAS QUE R1 SIGNIFICA FENILO, R2 Y R3, JUNTO CON LOS ATOMOS DE CARBONO CON LOS QUE ESTAN ENLAZADOS, FORMAN EL RESTO TIOFENO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8002910A SE8002910L (sv) | 1980-04-18 | 1980-04-18 | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES501400A0 ES501400A0 (es) | 1982-02-16 |
| ES8203088A1 true ES8203088A1 (es) | 1982-02-16 |
Family
ID=20340763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES501400A Expired ES8203088A1 (es) | 1980-04-18 | 1981-04-15 | Un metodo para la preparacion de 3,8-dialcohilxantinas |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4546182A (es) |
| EP (1) | EP0038784B1 (es) |
| JP (1) | JPS56166191A (es) |
| AT (1) | ATE10099T1 (es) |
| AU (1) | AU543122B2 (es) |
| CA (1) | CA1156229A (es) |
| DD (1) | DD158400A5 (es) |
| DE (1) | DE3166893D1 (es) |
| DK (1) | DK151631B (es) |
| ES (1) | ES8203088A1 (es) |
| FI (1) | FI69465C (es) |
| GR (1) | GR82347B (es) |
| HU (1) | HU185254B (es) |
| IE (1) | IE51106B1 (es) |
| NO (1) | NO811161L (es) |
| NZ (1) | NZ196829A (es) |
| PH (1) | PH16264A (es) |
| PL (1) | PL134762B1 (es) |
| PT (1) | PT72881B (es) |
| SE (1) | SE8002910L (es) |
| ZA (1) | ZA811729B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| US4710503A (en) * | 1985-02-07 | 1987-12-01 | Euroceltique S.A. | 6-thioxanthine derivatives |
| GB8618931D0 (en) * | 1986-08-02 | 1986-09-10 | Euro Celtique Sa | 6-thioxanthines |
| US5298508A (en) * | 1988-07-19 | 1994-03-29 | The United States Of America As Represented By The Department Of Health And Human Services | Irreversible inhibitors of adenosine receptors |
| JP2843634B2 (ja) * | 1989-03-06 | 1999-01-06 | 協和醗酵工業株式会社 | キサンチン誘導体 |
| IT1229195B (it) * | 1989-03-10 | 1991-07-25 | Poli Ind Chimica Spa | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. |
| AU5436790A (en) * | 1989-04-19 | 1990-11-16 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Sulfer-containing xanthine derivatives as adenosin antagonists |
| CA2030112A1 (en) * | 1989-11-24 | 1991-05-25 | Yasuo Ito | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same |
| US5366977A (en) * | 1992-09-29 | 1994-11-22 | The United States Of America, As Represented By The Department Of Health And Human Services | Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners |
| DE4311538C1 (de) * | 1993-04-07 | 1994-10-06 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von 1,3-Dimethyl-4,5-diaminouracil |
| AU6781194A (en) * | 1993-05-03 | 1994-11-21 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
| AU2603197A (en) | 1996-04-10 | 1997-10-29 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Use of an a1 adenosine receptor agonist to treat cerebral ischaemia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53890B2 (es) * | 1972-04-22 | 1978-01-12 | ||
| US4089959A (en) * | 1976-03-31 | 1978-05-16 | Cooper Laboratories, Inc. | Long-acting xanthine bronchodilators and antiallergy agents |
| CA1077932A (en) * | 1976-03-31 | 1980-05-20 | Berlex Laboratories, Inc. | Xanthine compounds and method of treating bronchospastic and allergic diseases |
| SE416810C (sv) * | 1977-10-14 | 1982-07-19 | Draco Ab | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| SE7810946L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | Metod att behandla kronisk obstruktiv luftvegssjukdom |
-
1980
- 1980-04-18 SE SE8002910A patent/SE8002910L/xx not_active Application Discontinuation
-
1981
- 1981-03-09 AT AT81850039T patent/ATE10099T1/de not_active IP Right Cessation
- 1981-03-09 EP EP81850039A patent/EP0038784B1/en not_active Expired
- 1981-03-09 DE DE8181850039T patent/DE3166893D1/de not_active Expired
- 1981-03-16 ZA ZA00811729A patent/ZA811729B/xx unknown
- 1981-03-17 CA CA000373230A patent/CA1156229A/en not_active Expired
- 1981-04-01 PH PH25455A patent/PH16264A/en unknown
- 1981-04-03 NO NO811161A patent/NO811161L/no unknown
- 1981-04-08 IE IE769/81A patent/IE51106B1/en unknown
- 1981-04-14 DK DK168281AA patent/DK151631B/da active IP Right Grant
- 1981-04-14 DD DD81229229A patent/DD158400A5/de unknown
- 1981-04-15 NZ NZ196829A patent/NZ196829A/en unknown
- 1981-04-15 AU AU69555/81A patent/AU543122B2/en not_active Ceased
- 1981-04-15 ES ES501400A patent/ES8203088A1/es not_active Expired
- 1981-04-15 GR GR64702A patent/GR82347B/el unknown
- 1981-04-16 FI FI811212A patent/FI69465C/fi not_active IP Right Cessation
- 1981-04-16 PT PT72881A patent/PT72881B/pt unknown
- 1981-04-17 HU HU811020A patent/HU185254B/hu unknown
- 1981-04-17 JP JP5724181A patent/JPS56166191A/ja active Pending
- 1981-04-17 PL PL1981230737A patent/PL134762B1/pl unknown
-
1983
- 1983-08-16 US US06/523,731 patent/US4546182A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| SE8002910L (sv) | 1981-10-19 |
| ATE10099T1 (de) | 1984-11-15 |
| IE810796L (en) | 1981-10-18 |
| DK168281A (da) | 1981-10-19 |
| NZ196829A (en) | 1984-12-14 |
| JPS56166191A (en) | 1981-12-21 |
| PL134762B1 (en) | 1985-09-30 |
| CA1156229A (en) | 1983-11-01 |
| US4546182A (en) | 1985-10-08 |
| AU6955581A (en) | 1981-10-22 |
| FI69465C (fi) | 1986-02-10 |
| GR82347B (es) | 1984-12-13 |
| IE51106B1 (en) | 1986-10-01 |
| ZA811729B (en) | 1982-04-28 |
| EP0038784B1 (en) | 1984-10-31 |
| DK151631B (da) | 1987-12-21 |
| FI811212L (fi) | 1981-10-19 |
| FI69465B (fi) | 1985-10-31 |
| ES501400A0 (es) | 1982-02-16 |
| PT72881A (en) | 1981-05-01 |
| EP0038784A2 (en) | 1981-10-28 |
| DD158400A5 (de) | 1983-01-12 |
| PH16264A (en) | 1983-08-23 |
| HU185254B (en) | 1984-12-28 |
| NO811161L (no) | 1981-10-19 |
| PT72881B (en) | 1983-03-29 |
| AU543122B2 (en) | 1985-04-04 |
| DE3166893D1 (en) | 1984-12-06 |
| EP0038784A3 (en) | 1982-01-20 |
| PL230737A1 (es) | 1982-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES485188A1 (es) | Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas | |
| ES8203088A1 (es) | Un metodo para la preparacion de 3,8-dialcohilxantinas | |
| ES2001341A6 (es) | Un procedimiento de producir un derivado de acido guanidinometilbenzoico. | |
| ES8308570A1 (es) | Un procedimiento para producir 5'-fosfato de 1, beta d-arabino-furanosil-(e)-5-(2-halogenovinil) uracilo. | |
| EP0138344A3 (en) | Pyridazinones as beta-adrenoceptor antagonists | |
| ZA838831B (en) | New nitro aliphatic compounds,process for preparation thereof and use thereof | |
| DE3378265D1 (en) | Cycloaliphatic pharmaceutical compounds | |
| DK287282A (da) | Fremgangsmaade til fremstilling af adamantylethylaminer | |
| DE3277971D1 (en) | Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use | |
| CA1251463A (en) | SYNTHESIS OF HYDROXYL ANALOGS OR DERIVATIVES OF METHIONINE, AND OF THEIR ESTERS; SYNTHESIS OF 1-ACYLOXY-4-HYDROCARBYLTHIOPROPENE; PRODUCTS OBTAINED | |
| JPS5519268A (en) | Pyrimidine derivative and medical composition | |
| DE3262166D1 (en) | A new p-chlorophenoxyacetic acid derivative, its method of preparation and pharmaceutical composition | |
| GB2071097B (en) | 1-(acylamino-aryloxy)-3-alkynylamino-propan-2-ols processes for their preparation and pharmaceutical compositions containing them | |
| JPS6463520A (en) | Prolactin secretion inhibitor | |
| DE3065093D1 (en) | Therapeutic composition based on imidazoles, especially for the treatment of thromboses; imidazoles and process for their preparation | |
| ES8507520A1 (es) | Un procedimiento para la preparacion de nuevos compuestos de b-lactama | |
| KR830005222A (ko) | 만성 폐쇄성 기도 질병 및 심장혈관 질병치료용의 3,8-디알릴크산틴의 제조방법 및 그 조성물과 치료방법 | |
| ES8502128A1 (es) | Procedimiento para la preparacion de derivados de 6 -metilprednisolona | |
| JPS5414961A (en) | Novel 3-hydroxyazetidine-3-carboxylic derivative | |
| JPS5279081A (en) | Preparation of novel 7-methoxycephalosporins | |
| JPS53132597A (en) | Cytidylic acid derivative and its preparation | |
| JPS54112847A (en) | Preparation of novel 3alpha, 6alpha-dihydroxy-24-oxo-5beta-cholestane |